TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.940
-0.040 (-2.02%)
At close: Dec 5, 2025, 4:00 PM EST
1.980
+0.040 (2.06%)
After-hours: Dec 5, 2025, 7:50 PM EST
TuHURA Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -29.29 | -21.68 | -29.32 | -9.37 |
| Depreciation & Amortization | 0.07 | 0.12 | 0.18 | 0.37 |
| Other Amortization | 0.17 | 1.28 | 0.01 | - |
| Asset Writedown & Restructuring Costs | - | - | 16.22 | - |
| Stock-Based Compensation | 5.36 | 1.96 | 0.48 | 0.22 |
| Other Operating Activities | 0.19 | 0.31 | - | -0.29 |
| Change in Accounts Payable | -1.51 | 3.64 | 0.34 | 1.85 |
| Change in Other Net Operating Assets | 0.03 | -0.36 | 0.15 | -0.29 |
| Operating Cash Flow | -24.67 | -14.73 | -11.95 | -7.51 |
| Capital Expenditures | -0.07 | -0.06 | -1.3 | -0.04 |
| Cash Acquisitions | -2.06 | -5.99 | - | - |
| Investing Cash Flow | -2.13 | -6.05 | -1.3 | -0.04 |
| Long-Term Debt Issued | - | 28.57 | 2.69 | - |
| Long-Term Debt Repaid | - | -0.8 | - | -0.35 |
| Net Debt Issued (Repaid) | -1.37 | 27.77 | 2.69 | -0.35 |
| Issuance of Common Stock | 15.75 | 7.05 | - | - |
| Repurchase of Common Stock | - | - | -0.02 | - |
| Other Financing Activities | -4.46 | -5.05 | - | - |
| Financing Cash Flow | 9.91 | 29.77 | 2.66 | 16.25 |
| Net Cash Flow | -16.9 | 8.99 | -10.59 | 8.71 |
| Free Cash Flow | -24.74 | -14.79 | -13.25 | -7.54 |
| Free Cash Flow Per Share | -0.56 | -0.79 | -1.11 | - |
| Levered Free Cash Flow | -1.44 | -15.19 | -8.29 | - |
| Unlevered Free Cash Flow | -1.27 | -13.88 | -8.29 | - |
| Change in Working Capital | -1.48 | 3.29 | 0.49 | 1.56 |
Source: S&P Capital IQ. Standard template.
Financial Sources.